<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-NGA-T-NTBLCP</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Investing for impact against Tuberculosis</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Nigeria - Tuberculosis - National Tuberculosis &amp; Leprosy Control Programme - NTBLCP.  This program has the following goals: To ensure universal access to high-quality, patient-centred, prevention, diagnosis and treatment services for TB, TB/HIV and DR-TB by 2020..  Responsive and resilient health systems that promote universal access to quality health care services by 2020. The objectives of this program are: To increase case notification rate of all forms of TB from 55.1/100,000 population in 2017 to 287 per 100,000 population in 2020.  To increase TB treatment success rate from 85% in 2017 to 90% in 2020 among drug susceptible patients.  To enrol 100% of diagnosed DR-TB patients on appropriate treatment by 2020.  Strengthen health systems for delivery of packages of essential health care services</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM Nigeria</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM Nigeria</narrative>
  </participating-org>
  <participating-org role="3" type="10">
   <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="7f31d019-a508-45d4-9833-b4b9a0f65366" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="NGA-T-NTBLCP" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2018-08-22" type="1"></activity-date>
  <activity-date iso-date="2018-08-22" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Jean NOUBOUSSI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>jean.nouboussi@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Jean NOUBOUSSI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>jean.nouboussi@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="NG" percentage="100">
   <narrative xml:lang="EN">Nigeria</narrative>
  </recipient-country>
  <sector code="12263" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Tuberculosis</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="1.22" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="7.79" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="2.49" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="8.61" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="D8A4C47C-BD32-4DDC-98CD-FDAE0FD2B520" percentage="29.42" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Pharmaceutical Products (HPPP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="3.58" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="1.47" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="FDEDB289-7073-424F-8780-856D2FB8F704" percentage="0.01" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Infrastructure (INF)</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="3.57" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="0.73" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="2F782C08-F342-42A0-ABA7-BD8E9C920F54" percentage="9.37" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Payment for Results</narrative>
    </description>
   </budget-item>
   <budget-item code="DC588E6C-6B65-46A8-90D7-3ACCD004E54D" percentage="16.37" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Procurement and Supply-Chain Management costs (PSM)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="15.37" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-03-31"></period-end>
   <value currency="USD" value-date="2019-01-01">1508090</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-04-01"></period-start>
   <period-end iso-date="2019-06-30"></period-end>
   <value currency="USD" value-date="2019-01-01">8366648</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-07-01"></period-start>
   <period-end iso-date="2019-09-30"></period-end>
   <value currency="USD" value-date="2019-01-01">1277555</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-10-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2019-01-01">1980160</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="USD" value-date="2019-01-01">1132425</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="USD" value-date="2019-01-01">4552734</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-07-01"></period-start>
   <period-end iso-date="2020-09-30"></period-end>
   <value currency="USD" value-date="2019-01-01">13315228</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-10-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2019-01-01">7197399</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">4001906</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">3853585</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">17275264</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">3077951</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">4851457</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">3711256</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">18433073</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">3006727</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">3935473</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">8506076</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">15764874</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">3100915</value>
  </budget>
  <capital-spend percentage="2.49"></capital-spend>
  <transaction ref="cb8f0dd8-f613-421a-a6f5-2e76a152add1">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-02-14"></transaction-date>
   <value currency="USD" value-date="2019-02-14">30235171.55</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="6f494bb7-3899-4578-adb1-3625b1da3adc">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-05-20"></transaction-date>
   <value currency="USD" value-date="2019-05-20">50000</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="48be11f3-4f50-4cc9-98cb-7fe59206256f">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-09-24"></transaction-date>
   <value currency="USD" value-date="2019-09-24">257139.54</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="26c57878-ef85-4bfd-b9c5-86b8ab948fd9">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-05-15"></transaction-date>
   <value currency="USD" value-date="2020-05-15">50000</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a714a9aa-2882-4fc0-a821-aae5730e2e1e">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-05-27"></transaction-date>
   <value currency="USD" value-date="2020-05-27">-16166.34</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="8534faf1-b6ff-4b2f-bf67-5c61906bef9c">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-05-27"></transaction-date>
   <value currency="USD" value-date="2020-05-27">312680.51</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="5f21ab0a-e154-4b2f-9877-9a72b563ec10">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-06-17"></transaction-date>
   <value currency="USD" value-date="2020-06-17">-312680.51</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7f355381-4530-40bb-a695-974ed4e4f66d">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-06-17"></transaction-date>
   <value currency="USD" value-date="2020-06-17">958447.25</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="00be7534-65fc-434e-8199-9297e18f3f14">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-07-08"></transaction-date>
   <value currency="USD" value-date="2020-07-08">-958447.25</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="873a988e-5f3b-44ea-bc1a-7bdf33b05621">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-07-08"></transaction-date>
   <value currency="USD" value-date="2020-07-08">972059.39</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="19c5abc3-e459-4082-8899-9c2b958f3d4d">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-07-24"></transaction-date>
   <value currency="USD" value-date="2020-07-24">-7554645.87</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7949439a-45fd-499f-b132-3aa87f5f5286">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-07-24"></transaction-date>
   <value currency="USD" value-date="2020-07-24">9687815.63</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="db58cb26-7356-4cde-a52f-a04e06cab8e6">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-12-14"></transaction-date>
   <value currency="USD" value-date="2020-12-14">36104125.75</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a16f08a9-e45b-403b-98ef-b9e202097ae4">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-06"></transaction-date>
   <value currency="USD" value-date="2021-01-06">529948.38</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="245e5cbc-912c-4d8e-ba37-41ff011ebbee">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-26"></transaction-date>
   <value currency="USD" value-date="2021-01-26">-36104125.75</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="241d9860-65b5-46e2-9d71-8fd31eedfdf6">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-26"></transaction-date>
   <value currency="USD" value-date="2021-01-26">36104125.75</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="9e60c78a-1f8f-4a71-b39b-13a37695a0a9">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-10"></transaction-date>
   <value currency="USD" value-date="2021-02-10">-41911.88</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="2be68482-a90c-47df-ab73-88417df5fa5e">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-10"></transaction-date>
   <value currency="USD" value-date="2021-02-10">29491.88</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="51211e85-e2ef-4999-a2a1-27e9a9a18eef">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-16"></transaction-date>
   <value currency="USD" value-date="2021-02-16">-29491.88</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="1135580f-29f7-41e0-aea0-a9d448b8ae67">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-16"></transaction-date>
   <value currency="USD" value-date="2021-02-16">12276.98</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="40b78e5f-d462-4350-b157-816234c9d38f">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-02-24"></transaction-date>
   <value currency="USD" value-date="2021-02-24">-12276.98</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="d02ae75a-4c13-457f-9719-74c219a3e626">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-07-07"></transaction-date>
   <value currency="USD" value-date="2021-07-07">50000</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="51e54ee1-6edf-4417-b4bd-d71292a8ae98">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-02-19"></transaction-date>
   <value currency="USD" value-date="2019-02-19">2592649.43</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7628329e-e5a5-46fe-a13a-2e82145c36a5">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-26"></transaction-date>
   <value currency="USD" value-date="2019-03-26">1180335.47</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b275fbe5-6a32-4b00-b583-566bac1d6787">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-05-10"></transaction-date>
   <value currency="USD" value-date="2019-05-10">113804.27</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3f1f46f4-7e4c-4dd4-b473-b1816bd11582">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-04"></transaction-date>
   <value currency="USD" value-date="2019-06-04">797899</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="ef04cb64-cbed-4327-b337-efb45cebb42b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-25"></transaction-date>
   <value currency="USD" value-date="2019-06-25">6863862.75</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b793655a-07e6-4e5e-bd53-958be7952aa3">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-25"></transaction-date>
   <value currency="USD" value-date="2019-06-25">846864</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0849ce14-7e8e-4625-a7bc-c0a37247bd8d">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-14"></transaction-date>
   <value currency="USD" value-date="2019-11-14">8979</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="ec84dd5a-cb16-4302-84f6-4b942b39c578">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-06"></transaction-date>
   <value currency="USD" value-date="2019-12-06">16.53</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a61b2cea-21b5-415b-aa30-4340e2b0f602">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-19"></transaction-date>
   <value currency="USD" value-date="2019-12-19">1330172.64</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="eb9d8c06-8fad-4c2f-b1cb-ecfe6ddcc2e2">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-19"></transaction-date>
   <value currency="USD" value-date="2019-12-19">225405.2</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="3fa299ed-f98e-48c8-a334-f6415023fab8">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-14"></transaction-date>
   <value currency="USD" value-date="2020-01-14">71367.41</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="ba333759-c7ad-4378-a479-7bfe9eb16652">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-30"></transaction-date>
   <value currency="USD" value-date="2020-01-30">1102</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="58bc4777-bfff-446c-8cec-758f525de8ad">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-13"></transaction-date>
   <value currency="USD" value-date="2020-02-13">3964427.73</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="ab782c53-aa4a-480f-9bec-dd9974831ee4">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-18"></transaction-date>
   <value currency="USD" value-date="2020-02-18">15346.86</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="e14731f8-d87c-4c7b-9e79-da1b0c1ae92b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-18"></transaction-date>
   <value currency="USD" value-date="2020-02-18">50000</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="58b0394a-8616-4841-b5c3-a65f3d6ec0c8">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-27"></transaction-date>
   <value currency="USD" value-date="2020-02-27">20951</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="efeed461-82f6-495a-89a1-223e6e23e052">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-27"></transaction-date>
   <value currency="USD" value-date="2020-02-27">31402.61</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c30a2512-a54e-46c6-a40d-1ba95a386dd7">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-19"></transaction-date>
   <value currency="USD" value-date="2020-05-19">221.14</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a82b4203-b471-4366-a7c5-738212f852b9">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-24"></transaction-date>
   <value currency="USD" value-date="2020-06-24">4790839.36</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0559a998-cabe-4b5c-bf62-d0e0ee180802">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-24"></transaction-date>
   <value currency="USD" value-date="2020-06-24">65852.48</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0768426f-db40-4785-aa7d-497768ceeae2">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-14"></transaction-date>
   <value currency="USD" value-date="2020-07-14">3877.94</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7bf0de06-1955-4622-846b-17daa6e6d4b4">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-29"></transaction-date>
   <value currency="USD" value-date="2020-07-29">797899</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b27c2de4-a3f7-47d1-a8bb-15c02792770e">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-19"></transaction-date>
   <value currency="USD" value-date="2020-08-19">14331.1</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b4057ca7-4024-477f-95ba-34ffbc08cba0">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-19"></transaction-date>
   <value currency="USD" value-date="2020-08-19">2861721.63</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="5ca695e8-86c9-47cd-8459-2ce8c925c6a9">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-24"></transaction-date>
   <value currency="USD" value-date="2020-08-24">571013.92</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="252dd5cc-997f-4104-b0cb-c986a0489d56">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-01"></transaction-date>
   <value currency="USD" value-date="2020-10-01">272918.11</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="9377b341-4651-49e2-a702-b795da40f7ee">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-04"></transaction-date>
   <value currency="USD" value-date="2020-11-04">3357606.25</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a1518f82-9486-4d27-8c24-a34d97e197d4">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-06"></transaction-date>
   <value currency="USD" value-date="2020-11-06">57537.92</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="62282bf6-5478-41d9-a48c-84eadede526f">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-19"></transaction-date>
   <value currency="USD" value-date="2020-11-19">6141.9</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0a01b2af-fff6-47eb-a3e3-703cc4065c4d">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-26"></transaction-date>
   <value currency="USD" value-date="2020-11-26">11.42</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a473c3f0-b17e-4f7c-99d7-d9a055b3e4c4">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-27"></transaction-date>
   <value currency="USD" value-date="2020-11-27">50000</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="25b990a4-c8d1-4619-916b-e2a79c78edc3">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-09"></transaction-date>
   <value currency="USD" value-date="2020-12-09">536118.37</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="688aaee5-f31a-48b5-a908-6d7384e349b9">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-10"></transaction-date>
   <value currency="USD" value-date="2020-12-10">24788.2</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="477ebe85-bb4a-4a4b-9ac8-ae99b89f65dc">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-11"></transaction-date>
   <value currency="USD" value-date="2021-01-11">529948.38</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="104f0838-660b-4bcb-b7a1-bae0f1733719">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-05"></transaction-date>
   <value currency="USD" value-date="2021-02-05">4001908.23</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b4c5dca7-08b3-44d0-aa38-de30970ffdb4">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-19"></transaction-date>
   <value currency="USD" value-date="2021-02-19">868058.89</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0fe9b973-f3c9-4592-a24c-849591f12fe2">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-05"></transaction-date>
   <value currency="USD" value-date="2021-03-05">4879.5</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="26071add-3eb5-4a9f-8d2c-d44d2b40b2b9">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">166664.77</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="d21690f5-1c17-45d7-8d8d-b7731c2b860b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-21"></transaction-date>
   <value currency="USD" value-date="2021-05-21">869696</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="13a8f9ce-3c8c-4ac2-909c-8e421bfaa583">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-24"></transaction-date>
   <value currency="USD" value-date="2021-06-24">275138.97</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="e570d19f-5687-4223-8d8e-1dc6c0bd8582">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-01"></transaction-date>
   <value currency="USD" value-date="2021-07-01">154166.49</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="cba3c3aa-b556-488b-af29-5cf8f9de7df2">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-01"></transaction-date>
   <value currency="USD" value-date="2021-07-01">4951948.98</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="2ee4a2f0-e065-4602-914f-d00f1570dd9b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-01"></transaction-date>
   <value currency="USD" value-date="2021-07-01">697447.28</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="6f48ff7d-e1a0-4bac-82e4-483740710df2">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-07"></transaction-date>
   <value currency="USD" value-date="2021-07-07">4951948.98</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to NGA-T-NTBLCP.</narrative>
   </description>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Tuberculosis &amp; Leprosy Control Programme</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for NGA-T-NTBLCP</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 10258 Denominator: 11734 Percentage: 87.42</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 11420 Denominator: 12521 Percentage: 91.21</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 11899 Denominator: 14082 Percentage: 84.50</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; private/non-governmental facilities</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 11862 Denominator: 104904 Percentage: 11.31</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 17250</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">PSM - Other 1: Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 11976 Denominator: 12606 Percentage: 95.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 100951 Denominator: 104904 Percentage: 96.23</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 11825 Denominator: 12521 Percentage: 94.44</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 12521 Denominator: 116879 Percentage: 10.71</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&amp;lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 188 Denominator: 12521 Percentage: 1.50</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 45297 Denominator: 116879 Percentage: 38.76</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="5-14"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 508 Denominator: 12521 Percentage: 4.06</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 71582 Denominator: 116879 Percentage: 61.24</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 97.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 26054 Denominator: 34247 Percentage: 76.08</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; community referrals</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 21667 Denominator: 104904 Percentage: 20.65</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 26226</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
    </title>
    <baseline year="2017">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1156</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1276 Denominator: 1975 Percentage: 64.61</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB regimen" value="New TB drugs"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 143 Denominator: 1975 Percentage: 7.24</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1756</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 1786</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB regimen" value="Short regimens"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1832 Denominator: 1975 Percentage: 92.76</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1925 Denominator: 1975 Percentage: 97.47</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 1975</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="TB regimen" value="New TB drugs"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 22</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="Age" value="&amp;lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 30</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="TB regimen" value="Short regimens"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 348</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&amp;lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 50 Denominator: 1975 Percentage: 2.53</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 630</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 699 Denominator: 1975 Percentage: 35.39</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 3155 Denominator: 3220 Percentage: 97.98</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Percentage: 79.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of DST laboratories showing adequate performance on External Quality Assurance</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 7 Denominator: 8 Percentage: 87.50</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
    </title>
    <baseline year="2017">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1473</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1516 Denominator: 2384 Percentage: 63.59</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 2216</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 2286</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 2316 Denominator: 2384 Percentage: 97.15</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 2384</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&amp;lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 68 Denominator: 2384 Percentage: 2.85</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="Age" value="&amp;lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 70</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 813</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 868 Denominator: 2384 Percentage: 36.41</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 104358</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 104904</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 104904</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Not documented"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 110726</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 120266</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 12521</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 14082</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3387</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="HIV test status" value="Not documented"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3953</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 40018</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 46601</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 64886</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 73665</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="Age" value="&amp;lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 7450</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="TB case definition" value="Bacteriologically confirmed"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 77647</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&amp;lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 86378</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 86869</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB case definition" value="Bacteriologically confirmed"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 9540</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 97454</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 91873 Denominator: 201707 Percentage: 45.55</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of people in contact with TB patients who began preventive therapy</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Age" value="&amp;lt;5"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1016</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 10788</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 9772</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 40009 Denominator: 104904 Percentage: 38.14</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 58.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 9632 Denominator: 12700 Percentage: 75.84</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Percentage: 86.00</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 87.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
    </title>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Percentage: 92.00</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for NGA-T-NTBLCP</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 60</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Text: 55.1</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 118</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 60</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 124</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 67</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 102</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 74</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 89</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 114</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB treatment coverage: Percentage of new and relapse cases that were notified and treated among the estimated number of incident TB cases in the same year (all form of TB - bacteriologically confirmed plus clinically diagnosed)</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 24.00</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Text: 24</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 56.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Percentage: 28.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 60.00</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 31</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 54.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 36.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 46.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 60.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 77.00</narrative>
     </comment>
    </baseline>
    <baseline year="2014">
     <dimension name="TB case definition" value="XDR TB"></dimension>
     <comment>
      <narrative xml:lang="EN">Text: 0%</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Text: 78%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Percentage: 77.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 78</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 77.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Percentage: 87.00</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Text: 86%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-07-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Percentage: 87.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 88</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for NGA-T-NTBLCP</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB/HIV mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 16</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Text: 18</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 17</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 14</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 17</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 16</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 15</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 14</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 13</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB cases with RR-TB and/or MDR-TB</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 4.30</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Text: 4.3%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.10</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 4.3</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.20</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.10</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.20</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.10</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.09</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB incidence rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 219</narrative>
     </comment>
    </baseline>
    <baseline year="2017">
     <comment>
      <narrative xml:lang="EN">Text: 219</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-07-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 210</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 219</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 215</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-01-01"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 206</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 217</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 216</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 214</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
